Spectral Gains Clarity Following FDA Meeting On PMA For Sepsis Therapy

(RTTNews) - Spectral Medical Inc. (EDT.TO), a late-stage theranostic company, on Friday announced updates regarding its 100-day meeting with the U.S. Food and Drug Administration (FDA) for Toraymyxin in treating sepsis. Sepsis is a life-threatening illness defined by the entry